Press release 2010-02-25


C-RAD AB with its three wholly owned subsidiaries
are all active in the field
of radiation therapy. A number of companies have
shown great interest for the
GEMini ED system and have started evaluations of
the image quality and its
technical performance. 

C-RAD Gemini system is
based on technology originally developed at CERN in
Switzerland. Since then,
the technology has been developed for use in medical
applications by Professor
Anders Brahme and his team at the Karolinska
Institutet in Stockholm. C-RAD
holds three patents, which ensures the
protection of the unique technology.


The C-RAD GEMini detector has a number of unique features. Opposite to
present
products on the market GEMini can be used both to make images with
conventional
x-ray and by using the beam of the radiation therapy machine.
Gemini ED is
mainly intended for use with the beam of the therapy unit. The
image quality
has been approved by a first potential customer and as a result
negotiations
have started. This company also has an interest to use the system
for IGRT or
so called Image Guided Radiation Therapy. Evaluations with other
companies will
be started. 

Two other companies have an interest to use the
C-RAD GEMini system for fluence
measurements when treating patients. A letter
of intent, was for this
application, signed with IBA Dosimetry. Based on a
requirement specification, a
technical and commercial evaluation is running.

 

Erik Hedlund, CEO, C-RAD AB:

"In 1998 the development of the GEMini
technology started at the Karolinska
Institutet in Stockholm. Since 2005 the
group at C-RAD Imaging has been working
hard to reach performances of the
detector, required by clinics and companies
working in radiation therapy.


In 2010 C-RAD Imaging is expecting to make first deliveries of the
GEMini
detector. In addition diode detectors of 4.3 MSEK to IBA Dosimetry will
be
delivered.” 

 

For further information: 

Erik Hedlund, CEO C-RAD
AB, Telefon 018 - 66 69 31, E-post erik.hedlund@c-rad.se